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Iowa Medication Safety and Effectiveness Statewide Strategic Plan 
FINAL, V5 
PROPOSED GOALS, OBJECTIVES, AND TACTICS 
 
 
Purpose: Improve the effectiveness, coordination, and safety of medication use in Iowa.  
 
 
Goal 1- Medication Effectiveness (Every medication is assessed  to ensure  it has an intended medical 
use, is effective and safe, and is able to be taken by the patient as  intended) 
 Objective 1.1: Identify strong practices and align state strategies to maximize 
effectiveness.   
o Tactic 1.1-A:  Develop a web-based repository of medication safety information 
including case for change, basic information and links to other available 
state/national resources. 
o Tactic 1.1-B:  Develop an aligning, core educational strategy targeting 
physicians, providers, pharmacists, hospital, long-term care, public health, 
patients/caregivers.  
o Tactic 1.1-C: Use the Choosing Wisely Campaign to promote medication safety, 
adherence, and effectiveness.  
o Tactic 1.1-D: Promote strong practices in Antibiotic Stewardship.  
o Tactic 1.1-E: Promote strong practices in improving medication adherence. 
o Tactic 1.1-F: Promote best practices and the use of high-harm medications.  
 Objective 1.2: Promote common strategies to engage patients and families to advance 
medication effectiveness and safety. 
o Tactic 1.2-A:  Develop a statewide patient and family engagement strategy. 
o Tactic 1.2-B:  Develop a medication safety related patient and family 
engagement measure set. 
o Tactic 1.2-C: Promote patient experience measures in the national CAHPS 
initiative.  
o Tactic 1.2-D: Promote medication reconciliation.  
 
Goal 2- Medication Safety (Routinely achieve patient goals with zero tolerance for preventable harm) 
 Objective 2.1: Align medication safety improvement initiatives with national health 
care transformation efforts. 
o Tactic 2.1-A:  Deploy the National Action Plan for Adverse Drug Event Prevention 
in Iowa. 
o Tactic 2.1-B:  Create common Iowa metrics for high-harm medications 
(Anticoagulation/VTE, Glycemic Management, Opioids) 
o Tactic 2.1-C: Promote adoption of Health Information Technology to enable 
timely exchange of medication information among all providers to prevent 
harm.  
 Objective 2.2: Align Iowa federally-sponsored efforts (Iowa HEN, QIO, TCPI, SIM, and 
CCTs) to promote medication safety. 
o Tactic 2.2-A:  Promote hypoglycemic medication harm-reduction through Iowa’s 
Statewide Diabetes Strategy. 
o Tactic 2.2-B: Promote anticoagulation medication harm reduction through 
Iowa’s Statewide Cardiovascular and Stroke Strategy. 
o Tactic 2.2-C: Promote opioid harm-reduction.  
o Tactic 2.2-D: Promote anti-psychotic medication harm reduction. 
o Tactic 2.2-E: Promote strong practices in Antibiotic Stewardship.  
 
Goal 3- Coordination (Aligned clinical strategies between stakeholders that ensures maximum 
medication effectiveness and safety) 
 Objective 3.1: Align public health and provider messaging to promote medication 
effectiveness and safety. 
o Tactic 3.1-A:  Develop common provider education modules for 
interprofessional continuing education (physician, nursing, and pharmacy). 
o Tactic 3.1-B:  Engage the academic pharmacy community in Iowa medication 
safety work. 
o Tactic 3.1-C:  Standardize/co-brand patient information on public health and 
provider websites. 
 Objective 3.2: Promote models that facilitate medication care coordination 
(Collaborative Practice Agreements, Medication Therapy Management, etc.) 
o Tactic 3.2-A:  Develop a set of measures that track coordination of community 
resources. 
o Tactic 3.2-B: Facilitate and promote the sharing of information across care 
continuums to enhance medication safety and collaborative care.  
o Tactic 3.2-C: Explore practice models that deliver sustainable medication care 
coordination.  
 Objective 3.3:  Reduce medication-related readmissions. 
o Tactic 3.3-A:  Standardize admission and discharge medication reconciliation 
processes and measures. 
o Tactic 3.3-B: Share strong practices with proven outcomes in reducing 
medication-related readmissions. 
 Objective 3.4: Develop strategies that reduce barriers to medication access. 
o Tactic 3.4-A: Encourage provider/patient discussions to identify social 
determinants of health, including health literacy, impacting medication safety 
and effectiveness. 
 
Goal 4- Data (Use data to monitor and advance “medication use system” strategies) 
 Objective 4.1:  Promote consistent definitions (ADE, others) to guide improvement 
efforts that align with national reporting initiatives.  
 Objective 4.2:  Develop Iowa outcomes measures in alignment with national reporting 
initiatives.  
o Tactic 4.2-A:  Align with 1305 and Million Hearts Campaign. 
 Objective 4.3:  Standardize inpatient and outpatient harm measurement in 
anticoagulation, glycemic management, and opioid use. 
 
